The State of Texas Attorney General Sues Acetaminophen Makers Regarding Autism Assertions
The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, claiming the companies withheld alleged dangers that the medication posed to pediatric brain development.
This legal action follows thirty days after President Donald Trump advocated an unsubstantiated connection between taking acetaminophen - referred to as acetaminophen - throughout gestation and autism in children.
The attorney general is suing the pharmaceutical giant, which once produced the drug, the sole analgesic approved for pregnant women, and the current manufacturer, which now manufacturers it.
In a official comment, he claimed they "deceived the public by profiting off of discomfort and pushing pills regardless of the risks."
The company states there is insufficient reliable data connecting Tylenol to autism spectrum disorder.
"These companies lied for decades, intentionally threatening numerous people to increase profits," Paxton, a Republican, declared.
The company stated officially that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the health of American women and children."
On its online platform, Kenvue also mentioned it had "regularly reviewed the pertinent research and there is insufficient valid information that shows a verified association between using paracetamol and autism."
Organizations acting on behalf of doctors and health professionals agree.
ACOG has said acetaminophen - the key substance in Tylenol - is one of the few options for expectant mothers to manage pain and fever, which can present serious health risks if left untreated.
"In over twenty years of studies on the consumption of paracetamol in gestation, not a single reputable study has successfully concluded that the use of acetaminophen in any trimester of gestation causes neurological conditions in children," the association commented.
This legal action mentions current declarations from the former administration in asserting the drug is potentially dangerous.
Recently, the former president generated worry from public health officials when he told expectant mothers to "struggle intensely" not to consume acetaminophen when sick.
The FDA then published an announcement that doctors should consider limiting the consumption of Tylenol, while also mentioning that "a causal relationship" between the medication and autism in minors has remains unverified.
Health Secretary Kennedy, who oversees the FDA, had pledged in April to conduct "extensive scientific investigation" that would determine the source of autism spectrum disorder in a matter of months.
But specialists cautioned that finding a single cause of autism spectrum disorder - believed by scientists to be the result of a intricate combination of genetic and surrounding conditions - would not be simple.
Autism spectrum disorder is a form of permanent neurological difference and condition that influences how individuals encounter and interact with the environment, and is recognized using physician assessments.
In his court filing, Paxton - a Trump ally who is seeking US Senate - claims Kenvue and J&J "intentionally overlooked and tried to quiet the science" around acetaminophen and autism spectrum disorder.
The case aims to force the firms "remove any commercial messaging" that states Tylenol is safe for women during pregnancy.
The court case echoes the grievances of a assembly of guardians of minors with autism and ADHD who took legal action against the makers of Tylenol in two years ago.
A federal judge dismissed the lawsuit, stating investigations from the plaintiffs' authorities was inconclusive.